These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 22081455)

  • 1. Heating-induced phase transition of bupropion hydrobromide polymorphs.
    Zhang G; Gao L; Zhang Z; Wang L; Shao M
    J Pharm Sci; 2012 Sep; 101(9):3091-5. PubMed ID: 22081455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystallization pathways and kinetics of carbamazepine-nicotinamide cocrystals from the amorphous state by in situ thermomicroscopy, spectroscopy, and calorimetry studies.
    Seefeldt K; Miller J; Alvarez-Núñez F; Rodríguez-Hornedo N
    J Pharm Sci; 2007 May; 96(5):1147-58. PubMed ID: 17455346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphic and kinetic investigation of adefovir dipivoxil during phase transformation.
    An JH; Choi GJ; Kim WS
    Int J Pharm; 2012 Jan; 422(1-2):185-93. PubMed ID: 22079719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Solid-state properties and crystallization behavior of PHA-739521 polymorphs.
    Sun CC
    Int J Pharm; 2006 Aug; 319(1-2):114-20. PubMed ID: 16720086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative phase analyses through the Rietveld method with X-ray powder diffraction data of heat-treated carbamazepine form III.
    Antonio SG; Benini FR; Ferreira FF; Rosa PC; Paiva-santos Cde O
    J Pharm Sci; 2011 Jul; 100(7):2658-64. PubMed ID: 21259240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thermodynamic relationships between nateglinide polymorphs.
    Bruni G; Berbenni V; Milanese C; Girella A; Cardini A; Viganò E; Lanfranconi S; Marini A
    J Pharm Biomed Anal; 2009 Dec; 50(5):764-70. PubMed ID: 19570642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of solvents and crystallization conditions on the polymorphic behaviors and dissolution rates of valsartan.
    Tran TT; Tran PH; Park JB; Lee BJ
    Arch Pharm Res; 2012 Jul; 35(7):1223-30. PubMed ID: 22864745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Investigation of the phase transitions occurring during and after the dehydration of xylazine hydrochloride monohydrate.
    Krūkle-Bērziņa K; Actiņš A
    Int J Pharm; 2014 Jul; 469(1):40-9. PubMed ID: 24732032
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of nicergoline polymorphs crystallized in several organic solvents.
    Malaj L; Censi R; Capsoni D; Pellegrino L; Bini M; Ferrari S; Gobetto R; Massarotti V; Di Martino P
    J Pharm Sci; 2011 Jul; 100(7):2610-22. PubMed ID: 21254066
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphism of Alprazolam (Xanax): a review of its crystalline phases and identification, crystallographic characterization, and crystal structure of a new polymorph (form III).
    de Armas HN; Peeters OM; Van den Mooter G; Blaton N
    J Pharm Sci; 2007 May; 96(5):1114-30. PubMed ID: 17455340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isothermal crystallization of Imwitor 742 from supercooled liquid state.
    Kawakami K
    Pharm Res; 2007 Apr; 24(4):738-47. PubMed ID: 17372699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solvent influences on metastable polymorph lifetimes: real-time interconversions using energy dispersive X-ray diffractometry.
    DeMatos LL; Williams AC; Booth SW; Petts CR; Taylor DJ; Blagden N
    J Pharm Sci; 2007 May; 96(5):1069-78. PubMed ID: 17455330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformational analysis and a crystal structure of bupropion, an antidepressant with dopamine reuptake blocking activity.
    Froimowitz M; George C
    J Chem Inf Comput Sci; 1998; 38(3):506-10. PubMed ID: 9611786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thermal and X-ray powder diffraction structural characterization of two benfluorex hydrochloride polymorphs.
    Maccaroni E; Malpezzi L; Panzeri W; Masciocchi N
    J Pharm Biomed Anal; 2010 Sep; 53(1):1-6. PubMed ID: 20347245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-throughput crystallization: polymorphs, salts, co-crystals and solvates of pharmaceutical solids.
    Morissette SL; Almarsson O; Peterson ML; Remenar JF; Read MJ; Lemmo AV; Ellis S; Cima MJ; Gardner CR
    Adv Drug Deliv Rev; 2004 Feb; 56(3):275-300. PubMed ID: 14962582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tris(hydroxymethyl) aminomethane salt of ramipril: synthesis, structural characterization from X-ray powder diffraction and stability studies.
    Bhattacharya A; Chattopadhyay B; Chakraborty S; Roy BN; Singh GP; Godbole HM; Rananaware UB; Mukherjee AK
    J Pharm Biomed Anal; 2012 Nov; 70():280-7. PubMed ID: 22877875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New solid modifications of nateglinide.
    Bruni G; Berbenni V; Milanese C; Girella A; Cardini A; Lanfranconi S; Marini A
    J Pharm Biomed Anal; 2010 Apr; 51(5):1054-9. PubMed ID: 20022441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal morphologies and polymorphs in tolbutamide microcrystalline powder.
    Li Destri G; Marrazzo A; Rescifina A; Punzo F
    J Pharm Sci; 2013 Jan; 102(1):73-83. PubMed ID: 23042550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The solid-state characterization of fusidic acid.
    Gilchrist SE; Letchford K; Burt HM
    Int J Pharm; 2012 Jan; 422(1-2):245-53. PubMed ID: 22100514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.